<SEC-DOCUMENT>0001683168-22-003357.txt : 20220510
<SEC-HEADER>0001683168-22-003357.hdr.sgml : 20220510
<ACCEPTANCE-DATETIME>20220509183639
ACCESSION NUMBER:		0001683168-22-003357
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		28
CONFORMED PERIOD OF REPORT:	20220509
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220510
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		22906634

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:RDNT="http://radnet.com/20220509">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_RDNT_radnet.com_20220509 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220509_20220509 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20220509.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-05-09to2022-05-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-09</xbrli:startDate>
        <xbrli:endDate>2022-05-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">UNITED STATES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 14pt"><b>FORM
<span id="xdx_90A_edei--DocumentType_c20220509__20220509_zKYYJTqdXKUe"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of
earliest event reported): <span id="xdx_900_edei--DocumentPeriodEndDate_c20220509__20220509_zEt0UdYIHUna"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May  9,
2022</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">_______________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20220509__20220509_zTZSeo3vEVJe"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityRegistrantName">RadNet, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt; width: 33%"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20220509__20220509_zJ36j3nws1ke"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="text-align: center; padding-left: 10pt; width: 34%"><span id="xdx_908_edei--EntityFileNumber_c20220509__20220509_zKEZwLh3cfze"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></span></td>
    <td style="text-align: center; width: 33%"><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20220509__20220509_zXvG4qVz6lgj"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt">(State or other jurisdiction
of incorporation)</td>
    <td style="text-align: center; padding-left: 10pt">(Commission File Number)</td>
    <td style="text-align: center">(IRS
Employer Identification Number)</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_901_edei--EntityAddressAddressLine1_c20220509__20220509_zoLjvRoQb1Ge"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20220509__20220509_zHYO1zeB2fPa"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20220509__20220509_zMnSdWFpNiqh"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span>
<span id="xdx_909_edei--EntityAddressPostalZipCode_c20220509__20220509_zOvLvZEmeT58"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive
Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90D_edei--CityAreaCode_c20220509__20220509_zreBlbvBndKj"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:CityAreaCode">(310)</ix:nonNumeric></span> <span id="xdx_90C_edei--LocalPhoneNumber_c20220509__20220509_z0k8sJnTt6Rh"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:LocalPhoneNumber">478-7808</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s Telephone
Number, Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_909_edei--WrittenCommunications_c20220509__20220509_zKsa0sxTGNB"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20220509__20220509_zZqJIKmPZCja"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20220509__20220509_zYZdv99CGs6c"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20220509__20220509_zpYMUEOEZWR9"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Title of Each Class</span></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 34%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Trading Symbol(s)</span></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Name of each exchange on which registered</span></span></td></tr>
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--Security12bTitle_c20220509__20220509_zwKCGWCR3Fy7"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:Security12bTitle">Common Stock, $.0001 par value</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20220509__20220509_zQNvaMESxA7i"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--SecurityExchangeName_c20220509__20220509_zA5z9JFeyJq4"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ Global Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company&#160;&#160;&#160;</span><span style="font-family: Wingdings"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20220509__20220509_zXlmIkICDPAg"><ix:nonNumeric contextRef="From2022-05-09to2022-05-09" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;
</span><span style="font-family: Wingdings">&#168;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in">Item 2.02</td><td>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 9, 2022 RadNet,
Inc. (&#8220;RadNet&#8221;) issued a press release and held a conference call regarding our financial results for the quarter ended March 31, 2022. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript of
the conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Current
Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report,
including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement or other document filed
with the Commission.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td style="text-align: justify"><b>FINANCIAL STATEMENTS AND EXHIBITS.</b></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 15%"><span style="text-decoration: underline">Exhibit Number</span></td>
  <td style="width: 85%"><span style="text-decoration: underline">Description of Exhibit</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.1</td>
  <td><a href="radnet_ex9901.htm">Press Release dated May 9, 2022 relating to RadNet, Inc.&#8217;s financial results for the quarter
  ended March 31, 2022</a>.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.2</td>
  <td><a href="radnet_ex9902.htm">Transcript of conference call.</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>

<tr style="vertical-align: top; text-align: left">
  <td>104</td>
  <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SIGNATURE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%">Date:&#160;&#160;&#160;May 9, 2022</td>
    <td style="text-align: left; width: 50%"><b>RADNET, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">By: <span style="text-decoration: underline">/s/ Mark D. Stolper </span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Name: Mark D. Stolper<br />
    Title: Chief Financial Officer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in">&#160;</p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 15%"><span style="text-decoration: underline">Exhibit Number</span></td>
  <td style="width: 85%"><span style="text-decoration: underline">Description of Exhibit</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.1</td>
  <td><a href="radnet_ex9901.htm">Press Release dated May 9, 2022</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.2</td>
  <td>Transcript of conference call.</td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpNBbdLh4o4ZYwh3hYXpbg1I61/j+Rb2m2IIRCSc74cIUZiQ2tdI8NpWWRQYtPWyiEUeEFGc0bvSLe7BPws8KqtY2Vcv/7AlDyDnpmPY+XvvfOhLVYJyMVExpMoBDlL5BTyvQg6PSVz0RUap1UNylSQM7Ws0Sl+Dx9K9SJDzbtPOiJbTSaBcCwH+QORDCM40EM9iW8WsiwVwaivQGyY7m0Xc7eOGljV2PgsO6D/Dr7iWkkg -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 99.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 74.25pt; width: 172.5pt"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RadNet Reports First Quarter Financial Results with Record Revenue
and Adjusted EBITDA<SUP>(1)</SUP> from Imaging Center Operations and Revises Upwards 2022 Financial Guidance Ranges </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Revenue increased 8.4% to $341.8 million in the first quarter of 2022
from $315.3 million in the first quarter of 2021; Excluding Revenue from our Artificial Intelligence (&ldquo;AI&rdquo;) reporting segment,
Revenue from the Imaging Center segment in the first quarter of 2022 was $341.2 million, an increase of 8.2% from last year&rsquo;s first
quarter</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Excluding losses from our AI reporting segment and Provider Relieve Funding
received in last year&rsquo;s first quarter, Adjusted EBITDA<SUP>(1)</SUP> from Imaging Centers was $41.7 million in the first quarter
of 2022 as compared with $40.1 million in the first quarter of 2021, an increase of 4.1%; Adjusted EBITDA<SUP>(1)</SUP>, unadjusted for
losses from our AI reporting segment and Provider Relief Funding, was $38.1 million in the first quarter of 2022 as compared with $45.5
million in the first quarter of 2021</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Per share Diluted Net Income for the first quarter of 2022 was $0.05,
compared with a per share Diluted Net Income of $0.18 for the first quarter of 2021; After adjusting for certain unusual or one-time items
impacting the quarter and AI losses, Adjusted Loss<SUP>(3)</SUP> was $8.3 million and diluted Adjusted Loss Per Share<SUP>(3)</SUP> was
$(0.15) for the first quarter of 2022</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Aggregate procedural volumes increased 8.8%; Same-center procedural volumes
increased 6.6% compared with the first quarter of 2021</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>During the first quarter, we completed the acquisitions of Quantib B.V.
and Aidence Holding B.V., two Netherlands-based AI companies focused on prostate and lung cancer screening, respectively </I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet revises full-year 2022 guidance levels to increase Revenue and
Adjusted EBITDA<SUP>(1)</SUP> ranges</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, May 9, 2022 &ndash;
RadNet, Inc. (NASDAQ: RDNT),</B> a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging
services through a network of 351 owned and operated outpatient imaging centers, today reported financial results for its first quarter
of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented, &ldquo;Despite being impacted in January by the Omicron variant of COVID-19, we produced the highest first
quarter Revenue and Adjusted EBITDA<SUP>(1)</SUP> from our imaging center operations in our Company&rsquo;s history. Revenue increased
8.2% and Adjusted EBITDA<SUP>(1)</SUP> increased 4.1% from last year&rsquo;s first quarter, after excluding the AI reporting segment and
adjusting for CARES Act Provider Relief Funds received in last year&rsquo;s first quarter.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Given the positive trends we are experiencing
in our business and the strong financial performance of the first quarter, we have elected to revise certain guidance levels upwards in
anticipation of financial results that we project to exceed our original expectations. We have increased 2022 guidance ranges for Revenue
and Adjusted EBITDA<SUP>(1)</SUP>,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;In mid-January, we
completed the acquisitions of two AI companies, Aidence Holding B.V. and Quantib B.V. The combination of these two companies with RadNet&rsquo;s
existing DeepHealth, Inc. mammography AI operations formed our new Artificial Intelligence reporting segment. The two acquisitions, along
with DeepHealth, provide RadNet with the developing technology underpinning future offerings for widespread cancer screening programs
for the three most prevalent cancers (breast, lung and prostate). We currently have three AI submissions pending approval with the FDA
for advanced breast, lung and prostate diagnostic algorithms. Their ultimate approval, if obtained, should enable us to offer large-scale,
cost-effective population health programs designed to positively impact the management of three of the most prevalent cancers. Though
we project losses for the next 24 months from the investments we are making in these new technologies, we continue to be more convinced
than ever that AI will have a significant impact on the growth and cost structure of our business in the coming years.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the first quarter of 2022, RadNet reported
Revenue from its Imaging Center reporting segment of $341.2 million and Adjusted EBITDA<SUP>(1)</SUP> Excluding Losses from AI reporting
segment of $41.7 million. Revenue increased $25.8 million (or 8.2%) and Adjusted EBITDA<SUP>(1)</SUP> Excluding Losses from the AI reporting
segment and Provider Relief Funding increased $1.7 million (or 4.1%). Including our AI reporting segment Revenue of $599,000, Revenue
was $341.8 million in the first quarter of 2022, an increase of 8.4% from $315.3 million in last year&rsquo;s first quarter. Unadjusted
for AI reporting segment Adjusted EBITDA<SUP>(1)</SUP> losses of $3.6 million in the first quarter of 2022 and $811,000 in the first quarter
of 2021 and $6.2 million of Provider Relief Funding received in the first quarter of 2021, Adjusted EBITDA<SUP>(1) </SUP>for the first
quarter of 2022 was $38.1 million as compared with $45.5 million in the first quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_Hlk102802505"></A>Net Income for the
first quarter of 2022 was $3.0 million as compared with $9.5 million for the first quarter of 2021. Diluted Net Income Per Share for the
first quarter was $0.05, compared with a Diluted Net Income per share of $0.18 in the first quarter of 2021, based upon a weighted average
number of diluted shares outstanding of 56.4 million shares in 2022 and 52.8 million shares in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_Hlk102802561"></A>There were a number
of unusual or one-time items impacting the first quarter including: $20.8 million of non-cash gain from interest rate swaps; $2.2 million
expense for legal settlements, $938,000 expense related to leases for our de novo facilities under construction that have yet to open
their operations and $4.3 million of expenses related to our AI division. Adjusting for the above items, Adjusted Loss<SUP>(3)</SUP> from
the Imaging Center reporting segment was $8.3 million and diluted Adjusted Loss Per Share<SUP>(3)</SUP> was $(0.15) during the first quarter
of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also affecting Net Income in the first quarter
of 2022 were certain non-cash expenses and unusual items including: $11.1 million of non-cash employee stock compensation expense resulting
from the vesting of certain options and restricted stock; $201,000 of severance paid in connection with headcount reductions related to
cost savings initiatives; and $648,000 of non-cash amortization of deferred financing costs and loan discounts related to financing fees
paid as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_Hlk102802643"></A>For the first quarter
of 2022, as compared with the prior year&rsquo;s first quarter, MRI volume increased 12.7%, CT volume increased 10.1% and PET/CT volume
increased 6.7%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams,
increased 8.8% over the prior year&rsquo;s first quarter. On a same-center basis, including only those centers which were part of RadNet
for both the first quarters of 2022 and 2021, MRI volume increased 9.8%, CT volume increased 7.3% and PET/CT volume increased 5.7%. Overall
same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased
6.6% over the prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2022 Revised Guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet amends its previously announced guidance
levels as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-decoration: underline; text-align: left">Original Guidance Range</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-decoration: underline; text-align: left">Revised Guidance Range</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: top; width: 35%; text-align: left">Revenue &ndash; Imaging Ctr Operations</TD><TD STYLE="text-align: left; width: 5%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 29%; text-align: left">$1,350 million - $1,400 million</TD><TD STYLE="text-align: left; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 30%; text-align: left">$1,360 million - $1,410 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-indent: -10pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1) </SUP>Excluding Losses from Artificial Intelligence Segment</FONT></TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$205 million - $215 million</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$208 million - $218 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Capital Expenditures</FONT><SUP>(a)</SUP></TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$85 million - $90 million</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$88 million - $93 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Cash Paid for Interest<SUP>(c)</SUP></FONT></TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$27 million - $32 million</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Unchanged</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Free Cash Flow</FONT> <SUP>(b)(2)</SUP></TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$80 million - $90 million</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Unchanged</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests, and excludes
New Jersey Imaging Network capital expenditures.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">Defined by the Company as Adjusted EBITDA<SUP>(1)</SUP> less Capital Expenditures and Cash Paid for Interest.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Excludes payments to counterparties on interest rate swaps.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Dr. Berger highlighted,
&ldquo;We have increased our guidance ranges for Revenue and Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt"><A NAME="a_Hlk102804341"></A>to
reflect the first quarter&rsquo;s strong financial results as compared with our original budget. Though we remain vigilant about the economic
environment, supply chain disruptions, inflation and the possibility of further variants of COVID-19, we have opportunities to expand
our operations in all of our markets both organically and through new acquisitions and joint ventures.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its first quarter
2022 results on Monday, May 9th, 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Monday, May 9, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. Eastern Time</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 888-204-4368</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 929-477-0402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">It is recommended
that participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and
archived webcasts available at </FONT>https://viavid.webcasts.com/starthere.jsp?ei=1546413&amp;tp_key=0e752f7a92
<FONT STYLE="font-size: 10pt">or http://www.radnet.com under the &ldquo;Investors&rdquo; menu section and &ldquo;News Releases&rdquo;
sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S.,
or 412-317-6671 for international callers, and using the passcode 6927836.</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I><A NAME="OLE_LINK2"></A>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RadNet, Inc. is the leading national provider of freestanding, fixed-site
diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of
351 owned and/or operated outpatient imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey
and New York. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total
of approximately 9,000 employees. For more information, visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking
statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and
strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified
by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo; &ldquo;seek,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;likely,&rdquo;
&ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references to future periods. Forward-looking statements in this
press release include, among others, statements we make regarding response to and the expected future impacts of COVID-19, including statements
about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to
service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">Forward-looking statements are neither historical
facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and
financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue
reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the ongoing impact of the COVID-19 pandemic on
our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&rsquo;s unprecedented
action regarding existing and potential restrictions and/or obligations related to citizen and business activity to contain the virus;
(ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility of a global economic recession;
(iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government action or patient choice; (iv)
measures we are taking to respond to the COVID-19 pandemic, including changes to business practices; (v) the impact of government and
administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining patient procedure volumes, changes
in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees that could lead to unavailability of
key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors and others we do business with; (ix) the impact
of return to work orders in certain states in which we operate; and (x) increased credit and collectability risks;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
our business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness, make
principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our
ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions nationally
and regionally in the markets in which we operate;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
the expansion of our business and improvements to our existing facilities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit rating
and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our ability to acquire, develop, implement and monetize artificial intelligence algorithms and applications;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates, or
credit markets;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings to
fund our current and future operations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and procedure
volumes; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services provided;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner physicians
or joint venture partners;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment and related
developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act;
</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators or
related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor costs
and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in
our facilities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political instability
or catastrophic events; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects related
to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or security
laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized
use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained in this
current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of
changed circumstances, new information, future developments or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes
that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes
this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in
the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should
not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled
measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this
release in the tables which follow.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief Financial
Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2022</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">70,713</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">134,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">159,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,062</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,783</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,384</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">52,475</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49,212</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">324,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">488,958</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">484,247</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">595,792</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">584,291</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total property, equipment and right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,084,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,068,538</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">570,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">513,820</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,339</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,603</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,009</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,135</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,746</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred tax assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,853</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">38,993</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,032</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,141,521</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,058,474</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">276,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">263,937</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,985</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,530</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,930</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,701</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,906</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,452</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Current portion of notes payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,164</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,164</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">381,298</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">374,784</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Long-term operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">590,665</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">577,675</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">740,707</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">743,498</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,401</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">16,360</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,720,071</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,712,317</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">RadNet, Inc. stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Common stock - $.0001 par value, 200,000,000 shares authorized; 56,197,826 and 53,548,227 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">409,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,592</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,761</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,421</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(90,260</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(93,272</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total RadNet, Inc.'s stockholders' equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">298,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">228,904</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">122,603</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">117,253</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">421,450</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">346,157</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,141,521</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,058,474</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Service fee revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">303,276</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">279,577</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">38,491</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">35,742</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total service revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">341,767</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">315,319</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,248</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">315,039</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">282,280</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,656</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss (gain) on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,307</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">201</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">285</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">343,486</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">303,914</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">(LOSS) INCOMEFROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,719</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,653</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,593</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,517</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,285</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,819</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,245</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">165</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">206</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other income</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(11,578</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(498</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,859</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,496</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,376</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,363</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,775</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,350</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,317</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,013</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,458</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.18</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.18</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">55,303,007</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">51,951,506</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">56,362,193</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">52,828,941</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF CASHFLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended March 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Net income</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">8,363</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">13,775</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Adjustments to reconcile net income to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,656</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization of operating lease assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,802</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,863</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,517</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,285</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">648</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,147</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss (Gain) non sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,307</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization of cash flow hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">923</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">925</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,819</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,245</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,102</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,248</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(501</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(23,904</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,493</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,065</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,308</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,417</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,507</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,387</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,133</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,859</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,291</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,519</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,416</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,031</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,157</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">901</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">28,084</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Purchase of imaging facilities and other acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25,123</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(57,075</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(36,558</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,424</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">117</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(61,564</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(87,348</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(827</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Payments on Term Loan Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,313</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,824</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,100</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Payments on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(87,100</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Net cash used in financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,313</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(11,651</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET DECREASE IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(63,893</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(70,927</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">134,606</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">102,018</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">70,713</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,091</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,448</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,267</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Cash paid during the period for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">34</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center"><B>RADNET, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center"><B>RECONCILIATION OF GAAP NET INCOME
(LOSS) ATTRIBUTABLE TO RADNET, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center"><B>COMMON SHAREHOLDERS TO ADJUSTED EBITDA<SUP>(1)</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center"><B>(IN THOUSANDS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Three Months Ended</P>
                                                                               <P STYLE="margin-top: 0; margin-bottom: 0">March 31</P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; text-align: left">Net Income Attributable to RadNet, Inc. Common Shareholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">3,013</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">9,458</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,376</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,593</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">201</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,656</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non Cash Employee Stock Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,102</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,248</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss (Gain) on Sale of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,307</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non-cash Change in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,819</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,245</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Other Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">206</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Legal Settlement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Non Operational Rent Expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">938</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; font-weight: bold; font-style: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 700">Including Losses from AI Segment and Benefit from Provider Relief Funding</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">38,132</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">45,503</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less Provider Relief Funding</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,248</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; font-weight: bold; font-style: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 700">Including Losses from AI Segment and Excluding Benefit from Provider Relief Funding</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">38,132</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">39,255</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;Plus Losses from AI Segment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,585</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">811</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: right; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; font-weight: bold; font-style: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 700">Excluding Benefit from Provider Relief Funding and Losses AI Segment</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">41,717</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">40,066</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS BREAKDOWN</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">First Quarter</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 77%; text-align: left">Commercial Insurance</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">57.2%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.3%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.4%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS BY MODALITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">First Quarter</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 36%">MRI</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">36.4%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">36.0%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">35.4%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">35.8%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.2%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.5%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.8%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.9%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.1%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.2%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.9%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.4%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.6%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.7%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.9%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE <FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Three Months Ended</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">March 31,</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">COMMON STOCKHOLDERS</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; text-align: right">3,013</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; text-align: right">9,458</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Subtract provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,248</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Subtract non-cash change in fair value of interest rate hedges (i)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,819</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,245</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Add COVID-19-related retention bonuses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,839</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Legal Settlement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Non-operational rent expenses (iii)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">938</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">AI Segment Losses (iv)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,301</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,554</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total adjustments - loss (gain)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,383</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,100</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Subtract tax impact of Adjustments (ii)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,108</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,185</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Tax effected impact of adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,275</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,915</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 10pt">TO RADNET, INC. COMMON SHAREHOLDERS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(11,275</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,915</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">ADJUSTED NET INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(8,262</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,543</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">COMMON STOCKHOLDERS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,362,193</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,828,941</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">ADJUSTED DILUTED NET INCOME PER SHARE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.15</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.05</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15pt; text-align: left">(i)</TD><TD STYLE="width: 5pt"></TD><TD>Impact from the change in fair value of the hedges during the quarter.&nbsp;&nbsp;Excludes
the amortization of the accumulation of the changes in fair value out of Other Comprehensive Income that existed prior to the hedges
becoming ineffective.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15pt; text-align: left">(ii)</TD><TD STYLE="width: 5pt"></TD><TD>Tax effected using 15.8% and 24.0% blended federal and state effective tax rate for the first
quarter of 2022 and 2021, respectively.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15pt; text-align: left">(iii)</TD><TD STYLE="width: 5pt"></TD><TD>Represents rent expense associated with de novo sites under construction prior to them becoming
operational.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15pt; text-align: left">(iv)</TD><TD STYLE="width: 5pt"></TD><TD>Representents losses before income taxes from Artificial Intelligence reporting segment.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U><BR STYLE="clear: both">
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> The Company defines Adjusted EBITDA
as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on
the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation. Adjusted EBITDA includes equity earnings
in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash
or extraordinary and one-time events taken place during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest comparable
GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare
industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not
be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a
measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented,
may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(2)</SUP> As noted above, the Company defines
Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid. Free
Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information
for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not
represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition
of Free Cash Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives
to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the
consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined
in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable
to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(3)</SUP> The Company defines Adjusted Earnings
(Loss) Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal of
equipment, loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation,
gain on extinguishment of debt, unusual or non-recurring entries that impact the Company&rsquo;s tax provision and any other non-recurring
or unusual transactions recorded during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Earnings (Loss) Per Share is reconciled
to its nearest comparable GAAP financial measure. Adjusted Earnings (Loss) Per Share is a non-GAAP financial measure used as analytical
indicator by RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should not be considered
a measure of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted Earnings Per Share
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as
presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_003.jpg" ALT=""><BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="image_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00339A">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00339A"><B>C O R P O R A
T E P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper, </B><I>Executive Vice President
and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger, MD, </B><I>President and Chief
Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00339A"><B>C O N E R E N
C E C A L L P A R T I C I P A N T S</B></FONT><B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp; Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #00339A"><B>P R E S E N T
A T I O N</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, and welcome to the RadNet Inc. First
Quarter 2022 Financial Results Conference Call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Today's conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the conference
over to Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, Inc. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet's first quarter 2022 financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we'd like to remind everyone
of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning anticipated future
financial and operating performance, RadNet's ability to continue to grow the business by generating patient referrals and contracts with
radiology practices, recruiting and retaining technologists, receiving third-party reimbursement for diagnostic imaging services, successfully
integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired operations as estimated, among others, are forward-looking
statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on Management's
current preliminary expectations and are subject to risks and uncertainties which may cause RadNet's actual results to differ materially
from the statements contained herein. These risks and uncertainties including those risks set forth in RadNet's reports filed with the
SEC from time to time, include RadNet's Annual Report on Form 10-K for the year ended December 31, 2021 to be filed shortly. Undue reliance
should not be placed on forward-looking statements, especially guidance on future financial performance which speaks only as of the date
it is made. RadNet undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances
after the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I'd like to turn the call over to Dr.
Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone, and thank
you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today's call, Mark and I plan to provide you
with highlights from our first quarter 2022 results, give you more insight into factors which affected this performance and discuss our
future strategy. After our prepared remarks, we will open the call to your questions. I'd like to thank all of you for your interest in
our Company and for dedicating a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we start, I would like to say, on behalf
of myself and the entire team at RadNet, we hope all of you and your loved ones are healthy and staying safe. We are extremely grateful
for all of our stakeholders, including our employees, business partners, lenders, and shareholders, and wish all you well during this
challenging time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let's begin. I'm very pleased with our performance
in the first quarter, especially in light of the impact we felt from the Omicron variant of COVID-19 during much of January. The surge
from Omicron not only disrupted normal patient flow in January, but it severely impacted our employee base, resulting in lower availability
and higher cost of labor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First week of January was the height of Omicron's
impact on our employee base, where 8.2% of our employee base was out with COVID. I'm happy to report that this impact was temporary and
that our procedural volume and labor force returned to more normal levels in February and March. As of last week, we had less than 1%
of our employees out sick with COVID and have experienced continuing strong procedural demand for our services subsequent to the end of
the first quarter. Despite this impact from COVID-19, we produced the highest first quarter revenue and Adjusted EBITDA from Imaging Center
operations in our Company's history.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue increased 8.2% and Adjusted EBITDA increased
4.1% from last year's first quarter, after excluding the AI reporting segment, which I'll discuss in a few minutes, and removing CARES
Act Provider Relief Funds received in last year's first quarter. The improvement from last year's first quarter was the result of ongoing
strong demand for our services and the continuing migration of patient procedures from hospitals to freestanding ambulatory outpatient
Imaging Centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the strong performance in this
year's first quarter and the confidence we are feeling for the remainder of the year, we have elected to increase key financial guidance
levels for 2022. Though we remain vigilant about the economic environment, labor shortages, supply chain disruptions, inflation, and COVID-19,
we are executing on opportunities to expand operations in all of our markets, both organically and through new acquisitions and joint
ventures, resulting in what we believe will be strong results for the year than originally projected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_006.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark, in his prepared remarks, we'll review the
increases we made to our revenue and EBITDA guidance levels upon releasing our financial results this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As many of you are aware, on January 20, we completed
the acquisitions of Aidence Holding B.V. and Quantib B.V. to address opportunities in lung and prostate cancer diagnosis and screening
with artificial intelligence. When combined with RadNet's existing DeepHealth mammography artificial intelligence, these AI businesses
provide RadNet with the basis for future offerings for widespread cancer screening programs for three of the most prevalent cancers: breast,
prostate, and lung.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aidence AI for chest and lung CT scanning is currently
used by customers in seven European countries, and its leading product is pending FDA approval for use in the United States. With customers
in 20 countries worldwide, Quantib solutions for prostate and brain MRI already have FDA 510 clearance in the United States and CE mark
in Europe. We are making progress with all three of our AI initiatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, we have three algorithms submitted
to the FDA, pending its review and approval. First, DeepHealth&rsquo;s SAIGE-DX Advanced Diagnostic Breast Cancer Algorithm was submitted
in January. Second, Aidence&rsquo;s Veye Lung Nodule Detection Solution was submitted to the FDA in December of last year. Last month,
Quantib's Prostate 2.0 Solution was submitted to the FDA. Our goal is to get these products approved through the FDA and have breast,
lung, and prostate algorithms rolled out through the RadNet contracted radiology groups between now and early next year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to believe that our investments in
AI will ultimately result in the improved productivity of our contracted radiologists and, more importantly, provide significant new revenue
streams from large-scale screening programs for some of the most prevalent chronic diseases and cancers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we hit it on our Fourth Quarter and Full Year
2020 Earnings Call, during the first quarter, we instituted segment reporting and divided our operations into the Imaging Center and artificial
intelligence reporting units. One of the objectives in doing this is to provide transparency for our stakeholders so that they can track
our progress in both core Imaging Center businesses and AI operations independently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we discussed on our last financial results
call, we anticipate that our AI reporting segment, consisting of DeepHealth, Aidence, and Quantib, will experience losses through 2023.
Our estimates for these losses during 2022 is between $12 million and $17 million. During the first quarter of 2022, the AI segment recorded
$599,000 of revenue and a loss of $3.6 million of Adjusted EBITDA, results which were in line with our projections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to the end of the first quarter on
April 1, we established a new joint venture in Frederick County, Maryland, with Frederick Health, a long-standing established community
health system in that market. In establishing this venture, RadNet contributed one multi-modality and three satellite routine imaging
facilities, and Frederick Health contributed two multi-modality imaging facilities. Upon establishing this joint venture, RadNet now has
approximately 29% of its facilities, 102 Imaging Centers, within health system partnerships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we have publicly stated, we believe that, within
the next three years, we would like to achieve over 50% of our facilities held within joint ventures with hospitals and health system
partners. We continue to enjoy the benefits from these partnerships, which include increased patient volumes, expanded breadth of services,
improved patient access, and a closer relationship with regional insurance companies and health plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our efforts throughout the pandemic,
during the first quarter, we continued to carefully manage our liquidity and financial leverage. We accomplished this despite having front-loaded
capital expenditures in the first quarter, as we typically do, and despite facing the longer accounts receivable collection cycle in the
first quarter as a result of the resetting of patient deductibles on January 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At first quarter's end, unadjusted for the losses
in our AI reporting segment, our leverage ratio was 3.3 times net debt to trailing 12-month EBITDA. Our liquidity also remained strong:
we ended the quarter with $70.7 million of cash and we were undrawn upon our $195 million revolving credit facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our days sales outstanding, DSOs, at March 2022
was 35.7 days, which we believe to be one of the best in the industry. The improvement in revenue cycle operations and collections has
significantly contributed to our ability to manage the challenges presented by COVID-19 and to make important investments for our future.
While we are committed to growing and expanding our business, we will also continue to follow a methodical and disciplined approach to
managing our financial leverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the call back
over to Mark to discuss some of the highlights of our first quarter 2022 performance. When he is finished, I will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark
Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'm now going to briefly review our first quarter
2022 performance and attempt to highlight what I believe to be some material items. I will also give some further explanation of certain
items in our financial statements, as well as provide some insights into some of the metrics that drove our first quarter performance.
I will also provide an update to 2022 financial guidance levels, which were released in conjunction with our 2021 year-end results in
March.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and
amortization, and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments and non-cash
equity compensation. Adjusted EBITDA includes equity and earnings of unconsolidated operations and subtracts allocations of earnings to
non-controlling interest in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.
A full quantitative reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet Inc. common shareholders is included
in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I'd now like to review our first
quarter 2022 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the first quarter of 2022, RadNet reported
revenue from its Imaging Center operations of $341.2 million and Adjusted EBITDA, excluding losses from AI reporting segment, of $41.7
million. Revenue increased $25.8 million, or 8.2%, and Adjusted EBITDA, excluding losses from the AI reporting segment and Provider Relief
Funding, increased $1.7 million, or 4.1%. Including our AI reporting segment revenue of $599,000, revenue was $341.8 million in the first
quarter of 2022, an increase of 8.4% from $315.3 million in last year's first quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_008.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unadjusted for AI reporting segment, Adjusted
EBITDA losses of $3.6 million in the first quarter of 2022 and $811,000 in the first quarter of 2021, and $6.2 million of Provider Relief
Funding received in the first quarter of 2021, Adjusted EBITDA for the first quarter of 2022 was $38.1 million as compared to $45.5 million
in the first quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net income for the first quarter of 2022 was $3
million as compared with $9.5 million for the first quarter of 2021. Diluted net income per share for the first quarter was $0.05 per
share compared with a diluted net income per share of $0.18 in the first quarter of 2021, based upon weighted average number of diluted
shares outstanding of 56.4 million shares in 2022 and 52.8 million shares in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual or one-time items
impacting the first quarter, including $20.8 million of non-cash gain from interest rate swaps, $2.2 million expense for legal settlements,
$938,000 expense related to leases for our de novo facilities under construction that have yet to open their operations, and $4.3 million
of expenses related to our AI division. Adjusting for the above items, adjusted loss from the Imaging Center reporting segment was $8.3
million and diluted adjusted loss per share was negative $0.15 during the first quarter of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also affecting net income in the first quarter
of 2022 were certain non-cash expenses and unusual items, including the following, $11.1 million of non-cash employee stock compensation
expense relating from the vesting of certain options and restricted stock, $201,000 of severance paid in connection with headcount reductions
related to cost savings initiatives, and $648,000 of non-cash amortization of deferred financing costs and loan discounts related to financing
fees as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the first quarter of 2022 as compared with
the prior year's first quarter, MRI volume increased 12.7%, CT volume increased 10.1%, and PET/CT volume increased 6.7%. Overall volume,
taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 8.8% over the prior
year's first quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a same-center basis, including only those centers
which were part of RadNet for both the first quarters of 2022 and 2021, MRI volume increased 9.8%, CT volume increased 7.3%, and PET/CT
volume increased 5.7%. Overall same-center volume, taking into account all routine imaging exams, increased 6.6% over the prior year same
quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first quarter of 2022, we performed 2,197,185
total procedures. The procedures were consistent with our multi-modality approach, whereby 76.1% of all the work we did by volume was
from routine imaging. Our procedures in the first quarter of 2022 were as follows, 316,784 MRIs as compared with 281,096 MRIs in the first
quarter of 2021, 196,461 CTs as compared with 178,510 CTs in the first quarter of 2021, 11,683 PET/CTs as compared with 10,950 PET/CTs
in the first quarter of 2021, and 1,672,257 routine imaging exams compared with 1,548,293 of all these exams in the first quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall, GAAP interest expense for the first quarter
of 2022 was $11.6 million. This compares with GAAP interest expense in the first quarter of 2021 of $12.8 million. Cash paid for interest
during the period, which excludes non-cash deferred financing expense, accrued interest, and payments made to swap counterparties, was
$7.4 million as compared with $8.3 million in the first quarter of last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet as of March
31, 2022, unadjusted for bond and term loan discounts, we had $693.8 million of net debt, which is our total debt at par value less our
cash balance. This compares with $623 million of net debt at March 31, 2021. Note that this debt balance includes New Jersey Imaging Network's
debt of $45 million, for which RadNet is neither a borrower nor a guarantor. As of March 31, 2022, we were undrawn on our $195 million
revolving line of credit and had a cash balance of $70.7 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_009.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2022, our accounts receivable balance
was $159.7 million, an increase of $24.7 million from year-end 2021. The increase in accounts receivable is mainly the result of the significant
increase in our procedural volumes and revenue, particularly during the second half of March, as well as the normal first quarter effect
on cash collections from the resetting of patient deductibles each year in January. Our days sales outstanding, or DSO, remains near the
lowest levels of our Company's history. Despite the increasing aggregate accounts receivable, our DSO was 35.7 days at March 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through March 31, 2022, we had total capital expenditures
net of proceeds from the sale of imaging equipment of $36.4 million. Note that each year we front-load the majority of our capital decisions
into the first part of the year, so Capex is disproportionately higher in the first half of the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to update and revise our
2022 Fiscal year guidance levels, which we released in conjunction with our fourth quarter and Full Year 2021 results. For revenue from
Imaging Center operations, we're increasing both the low end and the top end of our guidance range by $10 million to $1.360 billion to
$1.410 billion. For Adjusted EBITDA, excluding losses from the Artificial Intelligence segment, we're increasing both the low end and
the high end of our guidance ranges by $3 million to $208 million to $218 million. For capital expenditures, we're increasing both the
low end and the high end of our guidance ranges to $88 million to $93 million for the year. And for cash paid for interest and free cash
flow, our guidance levels remain unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted, to reflect the first quarter's strong
financial results as compared with our original budget, we've increased guidance levels for revenue and Adjusted EBITDA. Though we remain
vigilant about the economic environment, supply chain disruptions, inflation, and the possibility of COVID-19 increasing, we have opportunities
to expand our operations in all of our markets, both organically and through new acquisitions and joint ventures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to Medicare reimbursement for 2023,
there is nothing to report at this time. As is typical each year, we are expecting CMS to release a preliminary rate schedule sometime
in June or July. At which time, we will analyze CMS' proposal and our industry's lobbying group, the Association for Quality Imaging,
will provide CMS our industry's feedback. At this time of our second quarter financial results, we will be in a position to comment on
CMS' proposal and its impact, if any, upon RadNet's future results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'd now like to turn the call back to Dr. Berger,
who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we move towards the half year point of 2022,
we have a lot to be excited about for the remainder of the year. The demand for diagnostic imaging is greater than ever. Technology embedded
and state-of-the-art imaging equipment continues to improve. There have been advances in new contrast materials and radioactive pharmaceuticals.
Significant progress has been made in post-processing software. All of these factors are driving the increased clinical indications for
ordering diagnostic tests. As a result, our centers are extremely busy and we are pursuing expansion opportunities in all of our core
markets through a focus on same-center performance, de novo centers, health system partnerships, and tuck-in acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we mentioned on our last financial results
call, we have 15 de novo centers in development, with almost half of these growth initiatives within existing health system partnerships.
Though we are spending capital and absorbing operating certain expenses to construct these facilities, they will be important growth drivers
in late 2022 and beyond. Our acquisition pipeline remains active for tuck-in acquisitions in our core markets and we are at various stages
with new potential health system partnerships, as well with expanding existing joint ventures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_010.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we are advancing our AI strategy
and now have algorithms to address three of the top four most prevalent cancers. With these algorithms pending FDA approval, we expect
to have tools that lower the cost and increase the accuracy of cancer diagnostics in a form that can be packaged to create widespread
population health initiatives that today don't exist. While this AI can serve to lower our cost of delivering our services, more importantly,
AI could create substantial new revenue streams for our Company and the rest of the health care industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conclusion, we are excited and enthusiastic
about the opportunities that lie ahead for RadNet, and we look forward to updating you further in coming quarters regarding our progress.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. We'll go out first to Brian Tanquilut
with Jefferies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, guys. Good morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I guess my first question for you, Howard. We've
talked a lot about AI today, so just curious what you can share with us in terms of, number one, how do you think&mdash;once we get FDA
approval for all the pending applications you have, how do you think these will all integrate into your business, and what can it do to
RadNet, whether it's a differentiating factor or a competitive advantage? I guess related to that for Mark, how long do you think we'll
need to incur losses associated with these business lines?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, firstly, in terms of how it will impact
our business, it will be a lengthy process, because even beyond the approval of the various algorithms that we're now in front of the
FDA for, there are two other factors that will take time and will, I think, eventually be beneficial for RadNet as well as the other health
care providers and the industry as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Firstly, there is an implementation process and
that should not go unnoticed. This is not just a matter of getting the approval and turning on the various algorithms; they have to be
integrated into the existing EMR platforms, both for radiology as well as for the EMR records of our joint venture hospital partners and
referring physicians, and all of that takes time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Secondly, in terms of rolling this out, there's
an issue about reimbursement. In the instance of breast AI or breast imaging, right now, there is reimbursement and self-referral. That,
I believe, will continue to play a dominant role, and if anything, I think, artificial intelligence and greater consumer awareness will
help improve compliance. It's estimated that, perhaps, 25% to 50% more screening for breast cancer should be done than we currently are
experiencing. That problem was made worse during COVID, where there's an estimated 9 million to 10 million people who did not undergo
their normal routine screening. So, the case for breast cancer screening is a little bit more straightforward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_011.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Perhaps less straightforward is how do we take
other opportunities, particularly for lung screening, and make them more of the standard by which patients who have been determined to
have high risk are brought in for lung screening. That effort, which is currently ongoing in Europe at a greater pace than it is here
in the U.S., is one that we're going to have to work on diligently, not only with CMS and the federal government, but also with payors
here in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While there is current reimbursement by Medicare
and, for the most part, with a number of the payors, the compliance is disappointing in terms of how many people actually end up getting
this valuable tool.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of some changes in the United States
Public Service Task Force recommendations, there's an estimate that 15 million Americans are subject to high risk and should have lung
screening. Currently, only about 6% of those patients, or those candidates, actually get lung screening. We are seeing an increase in
our centers, and we're happy to see that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">But part of the process is that getting approval
for lung screening is not as easy as it is for the self-referral that we see for breast scanning. Patients have to go through a consultation,
then get a prescription for a lung scan, then get an authorization from the payor. That process is one that I think is handicapping a
better and more aggressive adoption here.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think part of what we're going to benefit from
is the experience that we're seeing in Europe, particularly in the United Kingdom, where the National Health Service has instituted an
aggressive program for patients with high risk for lung cancer and making access for these patients more valuable. That process is something
that we are actively involved with, both at local and federal levels, and we would hope that we will see benefits from our efforts here,
perhaps later this year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While artificial intelligence, I think is a great
opportunity, not only for breast and lung, for prostate and eventually for colorectal cancers; there is an education process, both on
the part of payors, their referring physicians, and ultimately, compliance and adoption by the public. But there's little doubt in my
mind that these tools will be an important part of screening and population health strategies in the future for which we strongly believe
that imaging is the gateway for population health initiatives, not only for cancers, but for other chronic diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think you can expect to hear a lot more from
us; but I think the next 12 to 15 months, we're going to work primarily on implementing these tools in Europe, where we, as I mentioned,
have had better adoption, particularly by the governments that have National Health Service programs, and here locally for the numerous
patients that already come into our facilities and for which the artificial intelligence initiatives here can strongly benefit the RadNet
patient base and radiologists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to the second part of your question,
Brian, we do expect, and we have said this publicly, that we will absorb losses in this AI reporting segment. As you can see, for the
first time in our Company's history, we have moved towards segment reporting. So, we have now, and you'll see it as when our 10-Q comes
out in Note 5, two different operating segments: the traditional Imaging Center segment, which has all of our operations, but for the
AI division as well as the AI segment. If you look at the segment reporting, we had about $599,000 worth of revenue this quarter from
AI and absorbed about $3.6 million of Adjusted EBITDA losses and a little over $4 million of net income losses from the AI segment this
quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect the revenue to grow in future quarters
this year, based upon the bookings of contracts that we're seeing with Aidence and Quantib, particularly in Europe. As we get FDA approval,
hopefully in the next quarter or two from the three algorithms that we have submitted with the FDA, meaning the Prostate 2.0 from Quantib,
the Aidence lung nodules low-dose CT scanning algorithm, as well as the more advanced DeepHealth diagnostic algorithm, we will gear up
some expenses towards the latter part of the year to, one, implement these solutions at the RadNet facilities with our contracted radiology
groups, as well as build the commercial and sales teams to start more aggressively marketing these solutions to other operators.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_012.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian, one other comment&hellip;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That makes a lot of sense. Go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let me take this opportunity to alert our investors
and analysts here. I want to point out that the White House has reinvigorated an opportunity, or an initiative I should say, for cancer
screening through Cancer Moonshot, which President Biden began to try to develop while he was Vice President in the Obama administration
and announced earlier this year that they were reinvigorating this. The mandate for Cancer Moonshot is to reduce cancer deaths by 50%
by 2050.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The indications are that the White House strongly
will recommend and try to implement new cancer screening tools, which we believe will be a huge opportunity for imaging providers to present
themselves to provide that kind of access and capabilities, and which will be substantially enhanced by artificial intelligence. So, I
think you can expect that RadNet will attempt to play a prominent role in helping shape the White House's efforts to increase cancer screening,
primarily breast cancer and lung cancer, initiatives that we will be recommending and actively working to help promote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If that is successful, I think there will be
a sooner rather than later adoption of the tools that will help identify patients at high risk and get them into the outpatient ambulatory
centers for screening cancers. Hopefully, we will be able to report more on our efforts and the efforts of the White House in these very
important initiatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome. Mark, I was looking at&mdash;there's
a <I>Wall Street Journal</I> article today about how hospitals are looking for raises on reimbursement in reaction to, obviously, increased
costs. So, just wondering what you're seeing in your business related to that, and are you having similar conversations that could see
rate growth going forward?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. I believe hospitals are starting to feel
the same pressure that all companies are feeling, whether you're in healthcare, or any other industry, which is the impact of the tight
labor market, shortage of labor, and the inflationary aspects associated with hiring and retaining employees. If you recall, when we produced
our original guidance levels in conjunction with our fourth quarter and Full Year 2021 results, we put about $15 million of additional
costs, or we built that into our guidance levels, because we saw that the labor market was quite challenging to attract and retain employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_013.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our employee base has always been in competition
with hospitals for technologists and other front-end healthcare workers. I think what's happening is the hospitals are now seeing this
impact, like we're seeing it, and the result is they're seeing their expenses go up and they're going to their payors to try to get a
higher reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We've had some of those similar discussions with
some of the larger regional and national payors, and we think we will be successful in some regards to try to get better pricing for our
services. These are ongoing discussions. They're one-off in nature, and I think we will be successful. But it's a battle, because they're
seeing, the payors themselves, and the health plans are seeing their costs going up as well for their own labor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think this is something that we're all trying
to work through, both from the revenue side, but as well as on the cost side. We're looking at all sorts of interesting ways to try to
lower our labor costs, or at least keep them in check. I think we mentioned towards the end of last year that we're implementing a project
on some of more of our advanced MRI systems, which will allow certain MRI techs to become what we call super techs, which will allow them
to control multiple machines in different facilities from one location, which will obviously allow us to utilize labor more efficiently.
It will also allow us to cover when employees are out sick, or on maternity leave, and that's one way that we're trying to reduce staffing
issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We've got a number of initiatives on the hiring
front, on the retention front, to also try to better recruit and retain existing employees. So, this is a challenge I think that every
company is feeling. In some ways, the fact that the hospitals are acknowledging this and trying to get higher pricing for their services
just highlights and is going to, I think, amplify the issue where hospital-based pricing is so much higher than ambulatory services,
like the independent Imaging Centers that we operate, where that's something that I think is going to aggressively get the payors even
more aggressive in trying to direct their business outside of the hospitals into freestanding facilities like the ones we operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian
Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That makes sense. Last question for me. You obviously
raised guidance today. Just curious, are you seeing better volumes? Are you seeing increased optimism in the recovery? Are you gaining
market share? Just curious, what the impetus is for raising guidance right now?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think it's primarily volumes that are being
driven higher than, perhaps, our initial conservative estimates were. That's as a result, I think, of people still recovering from COVID
and getting exams that they deferred. I also think it's a function of us deploying more equipment and upgrading some of our equipment
to allow for better throughput. As Mark mentioned, some of the state-of-the-art equipment that we're now able to put in, either brand
new, or upgrade existing scanners, have significantly, particularly in the case of MRI scanners, reduced scan times significantly, allowing
for greater throughput. As you might have seen in our volume numbers here, there was a disproportionate growth in MRI scanning relative
to the rest of the procedural volume we're doing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think some of the capital investments that we've
made and mostly, I think, the sophistication that we're bringing to the use of our capital to drive more volume because of high demand
are starting to take root. We hope to see that continue through the rest of the year; but as I mentioned in some of my remarks, there's
reasons why we're still cautious in our estimates given issues with the labor markets, given issues with the supply chain related to equipment
and other supplies, and related to the uncertainty of what the impact from COVID will continue to be as the anticipation of additional
surges are upon us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think driving more revenue, some slight pricing
increases are part of what we're seeing here early in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_014.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome. Thank you, guys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll go next to Mitra Ramgopal with Sidoti.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra
Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Hi. Good morning. Thanks for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark, I just wanted to follow up. You talked
about the labor challenges and inflationary environment on wages, etc. I know you had guided to about maybe $15 million of additional
salary and wage expense that you might be incurring this year. I was wondering if that number is changing in light of the still pretty
difficult environment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, we still feel comfortable with that $15 million
estimate for increased salaries, benefit, and wages. We haven't seen it get worse per se than when we put this guidance together towards
the end of last year and early in the first quarter. As of now, I think we're going to stick with that $15 million number. Obviously,
there's lots of ins-and-outs, both on the revenue side as well as the expense side, and levers that can be pulled if we see those costs
rising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to look at new ways to automate some
of our processes to rely less on human capital and more on technology. We did, as Dr. Berger mentioned, license some technology for MRI
scanning that improves the post-production software processing of our images that allows us to scan faster. We're using these remote technologists.
We've implemented in a lot of our facilities virtual waiting rooms that are more efficient to get patients in and out of our facilities.
We're doing everything we can to increase capacity, shorten scan times, and rely less on human capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the end of the day, we're a technology business.
We utilize high-tech scanners to take digital images. We're really an information processing business. All of the information is not only
on the scan side but on the patient demographic side, the billing side; it's all bits and bytes, and ultimately, we've got to find ways
as a company to try to capitalize on the fact that we're really in the information management business and not so much in the human capital
business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_015.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><BR>
Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. That's great. As we emerge in terms of
a post-pandemic environment, could you touch on the pipeline as it relates to M&amp;A and JV and the valuations you're seeing, is there
additional interest now versus maybe a year or two ago?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. We have an active pipeline of tuck-in transactions.
We did a couple of small tuck-ins at the end of last year, early in the first quarter, and that will continue to be the strategy of the
Company. We're finding that, for these transactions, they're a lot less competitive in the markets in which we currently operate. Outside
of the markets, our core seven markets, when larger transactions come available, they seem to be garnering a lot of attention from private
equity firms who are looking at those businesses as platform businesses, and they're going for significantly higher multiples than we've
typically paid for tuck-in transactions in our existing markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than entering the Arizona marketplace through
our relationship and our third joint venture with Dignity Health, we haven't really seen opportunities that were actionable in other areas
of the country. So, our M&amp;A pipeline really is focused on existing markets, further penetration of the geographic clusters that we're
currently in, and we believe that we can continue to buy those transactions in the four times to six times range. With our presence in
those markets, there usually are extraordinary synergies that we can get with those acquired operations that come both on the revenue
side as well as the cost structure side.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">M&amp;A will continue to be a big part of what
we do. If you look at our growth rate over the last 12 years or 13 years, we've grown the top line on a compound annual growth rate north
of 8%, and some portion of that, I'd say half to a little less than half of that, has been on average organic growth through same-center
performance. The other half has been through inorganic means such as M&amp;A with these tuck-in transactions as well as hospital joint
ventures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hospital joint ventures will continue also to
be a growth engine for us. Today, we have about 22 of these relationships, as Dr. Berger mentioned in his prepared remarks, with the new
joint venture that we established in Frederick, in Maryland, this quarter, 29% of all of our facilities, which represent 102 facilities
of our 350 facilities, are currently held within joint ventures. We've enjoyed those relationships there. The relationships with the hospitals
have been very advantageous with respect to our volumes. They have also helped us establish better relationships with the regional and
national payors, and they have provided significant patient access and quality for those patient communities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All three of these initiatives, meaning the same-store
sales focus as well as the M&amp;A transactions and JVs, will continue to be big parts of our strategy going forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks. Finally, I know it's still early
days for the Aidence and Quantib acquisitions. Just curious in terms of how the integration is coming along and are there any potential
cost synergies you think you can realize there?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><IMG SRC="image_016.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think it's a little too early for us to comment
on those. We're looking at the opportunities to create synergies in some of the back-office functions. There is also an opportunity, perhaps,
to shift some of our development work to Europe, where the cost structure is a little less expensive and where there appears to be a more
robust labor pool.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We've only really had the two new joint ventures
undertow (phon) here for about 90 days, so we're still working our way through that and integrating them more into the RadNet family than
we are looking deeper into the individual initiatives. But certainly, we are talking about some of those, and hopefully we'll have more
comments about those maybe by the third quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks again for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark
Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, there are no further questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Great. Thank you, all. Again, I would like to
take this opportunity to thank all of our shareholders for their continued support, and the employees of RadNet for their dedication and
hard work. Management will continue its endeavor to be a market leader that provides great services with an appropriate return on investment
for all stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your time today and I look forward
to our next call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This does conclude today&rsquo;s conference. We
thank you for your participation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #B @\# 2(  A$! Q$!_\0
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M/!7@I/ NG?88;R]NK&,@6Z7,AEDMU'1 Y^9@. -V6XY)ZUOT %%%% !1110
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MZ+ZG^M>N_#OX,Q^+-3^U7BG[#"V2,?ZT^G^)KVN&.'3+)458X88$& /E5 *
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M<\-:M9ZQI=XH:*>VD#J?8^A]0:\A^//_  2\^!W[0ADFUCP#HMGJDF2NH:9
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M8/\ A]I_B;QY>7-GIVIWRZ=;B"$S2/*4=\8';:C<U\TK_P ''_[.)_YBFO\
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M&\2VCJI^5[Z4*\Q/;*J43V*M7T[_ ,$H/@&OBBZ;7[Z'=I^CX"!AQ+,>0/\
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MG_!)<;O^"C_P9!Z?\)79?^C!7@?B7_D/WG_7>3_T(U[Y_P $E_\ E)!\&?\
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M#1#IR.V/2NH\&>-])^(?AVVU;0]2LM6TV[4-%=6LHEBD'L10!L4444 %%%%
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M'_HA:M?"S.3?,EZGHG_!8/\ :)\:_!'XB^#[7PKXBU#18+[3II)TMWVK*RR
M G\*^(->_;H^-K>+]%U&/XF:Y::?I+FXNHGF!2Y*E2B.#QMR#GVXKZK_ ."Z
M_P#R5/P'_P!@NX_]&BOSC\4:,OQ%^-OPM\#3320Z;XR\3V>GWI0X9HGN(HV&
M?<2$_A2AN54V/<O%/[37Q,\8JFM:AXJ\220:IN:*X$[I!.!P=A& 0/:N?TO]
MN7XM?LKZG!XP\,^*M4O[/394DU'1K^=KBTOH<@.-K$E6QR".E?JQ_P %%/V?
M_#-O^PAKMC8Z/8V,?A"RAGTP0PJGV7RW5<+@="A8'US7XR_$V-9OASKJ-RK6
M4I_)#1&UPE?E/Z!/V<OC7IO[1_P)\*>.])#+I_BK38=0B1OO1;U!*'W5LJ?<
M5@?M<_M3:/\ LG?"BX\0:E_I%W,3!I]F#AKJ;L/]T#DGT%>'?\$#;^;4/^"4
M?PQ>:1I64ZI$"QZ*NJ7:J/P4 ?A7SC_P6J^*5QXI_:4T_P -+)_H/AG38V*
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M;KA?K7V-_P %^/\ E*E\2/\ =T__ -(8*^.;/_CY3ZU^4Q_Y'"_Q_JC^S/\
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M._\ )%]4_P!Z'_T:E?T.?LH_\FQ?#O\ [%K3O_26.OYX_P!IW_DB^J?[T/\
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M\ZCS(V]"5/S*17M6: ,W0->35[90W[NZ11YL).&0UI9K@OC3\.-2\3:3]O\
M#MXVF^(;,;K>53A9?]A_4&OGK0_^"HEE\)O&#>%_BYI-UX;U&!MC7Z1$PMC^
M-EZX/JN10!]A9I'^X?I7-?#7XO>&?B_H*ZEX9U[2M<LW /FV=PL@3/9@"2I]
MC@UTCM\K?2@#^:7_ (+[<?\ !5#XD9_NZ?\ ^D,%?'EI_P ?4?UK],/^"S'_
M  3F^-GQY_X*)^.O%/A'X>:YKF@ZFME]GO+?R_+FV6<2-C+ \,I'2OF33/\
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MZC@=Q7[*L/Y5=3H9T^OJ?!O_  7;/_%M_ /_ &$[C_T4M?FC)]PU^K'_  6
M^!/B[XY>!_!EMX3T.\UJXT_4)YKA8,9C5HU4$Y([U\&_\.^?C-_T(.L?^0__
M (JH-#H/^"8_[<<7_!/;X+:YX3FT*3Q$^L:[-K(N$G\CR_,CC39C!Z>7USWK
MZ3_X?M6W_0@S?^!X_P#B:^3?^'?'QF_Z$/6/_'/\:3_AWS\9O^A!UC_R'_\
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M10 ;?:F^6OI3J* &K$%%.(R*** &^4*/*%.HH ;Y0H5-M.HH **** "BBB@
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M4+75M%UBUCO+*\MI!)#=0NH975@>00: -JBBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rdnt-20220509.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaCOSaPty5526YkxvmR9femary4q7iWx2yP1k1mWsWQO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:RDNT="http://radnet.com/20220509" elementFormDefault="qualified" targetNamespace="http://radnet.com/20220509">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20220509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20220509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rdnt-20220509_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rdnt-20220509_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20220509.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (( LT# 2(  A$! Q$!_\0
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MK?\ ??\ ]:J7]C?]-_\ QS_Z]']C?]-__'/_ *]'*PYXEW_A)D_Y]6_[[_\
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M /'/_KT?V5_TV_\ '?\ Z]'*P]I$T/\ A)D_Y]6_[[_^M1_PDR?\^K?]]_\
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MGV#ZS2[G1?\ "3)_SZM_WW_]:C_A)D_Y]6_[[_\ K5SM&:/93[!]9I=SHO\
MA)D_Y]6_[[_^M1_PDR?\^K?]]_\ UJYS-&:/93[!]9I=SH_^$F3_ )]6_P"^
M_P#ZU'_"3)_SZM_WW_\ 6KG,T9H]E/L'UFEW/0:*Y[_A*/\ IS_\B_\ UJZ&
MIE%QW-(5(S^%G+^)/^0C'_UR'\S3M(_X]'_ZZ'^0IOB3_D(Q_P#7(?S-.TC_
M (]'_P!\_P A1'<)[&A1115F(4444 )12TE !1110 E%+24 %%%% @I*6BF
ME%%% !24M% "4444 )12T4"$I*6B@!M%+10 VBEI*8A**6DH 3%)3J0B@0E)
M2T4P&T4M)0(2DQ3J2@!M)BGTF*8AM)3J2@!*0BEHH$,HIQ%)BF(;24ZDH ;1
M2T4"&8HIU(13 ;BDIU% AE%.Q24Q#:2G4E "8IM/I*!#:2G$4E,0E)3J2@0E
M)BG4E #:*4BDIB$HI:* &D4E.HQ0(;11BB@!**6DIB"BBB@!**6DH *2EHH$
M)12TE "44M)0 5Z%7GM>A5A7Z';@_M'+^)/^0C'_ -<A_,T[2/\ CT;_ 'S_
M "%-\2?\A&/_ *Y#^9IVD?\ 'H_^^?Y"L8[G74^$T**2BK,1:*** "BBB@ I
M*6B@!**** "DI:* $HHHH$%%%% "44M)3 **** $HI:2@ I*6B@0E%%% "4E
M.I* $Q24ZDIB$I*6B@!,4W%.HH$-I*<124P$I*=24 )24M% AI%)3J,4 ,HI
M:*8AM&*6DH$-(I*?2$4 ,HIV*2F(;24ZDH$-Q24_%)3 ;2$4[%)0(;24_%-Q
M3$)24ZDH ;28IU)B@0VBG4F*!#:*6C%,!M)BG44"&44ZD(IB$I*6B@!*0BEH
MH$-HI<4E "44M%,0E%%% !24M% "4444"$HI:2@ KT&O/J]!K"OT.[!_:.7\
M2?\ (1C_ .N0_F:=I'_'HW^^?Y"F^)/^0C'_ -<A_,TND_\ 'JW^^?Y"L8[G
M54V-"BDI:LQ"EI** %HI*6@ HHHH *2EHH 2BEI* "C%%% "44M)0(**** $
MHI:*8"4444 )12T4 )1110 E%+24""DI:* &TE.I* $I*=24Q"4F*=24 -HI
MU)B@0VBEHI@-HI:2@0E(13J2@!M)3L4E,0W%%+10 W%(13J*!#*2GD4VF(2D
MIU)0 VDQ3J2@0VBG4F*8AI%)3J3% #:2G44Q#:2G4E AN*2G48H ;24N**8A
M*2EHH$-Q24ZB@0VBEQ24P$HI:2@0F*2G4A% "4E+10 E%+24Q!24M% "44M)
M0 5Z!7G]>@5A7Z';@_M'+^)/^0C'_P!<A_,TND_\>K?[Y_D*3Q)_R$8_^N0_
MF:72?^/5O]\_R%8QW.JI\)?HHHJS 6BDI:!A1110 M%)10 M%%% !1110 E%
M+10 E%%% "44M% "4444""DI:*8"44N*2@ I*6B@!**6DH *2EHH$)28I:*
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M M%%% PI:2B@!:*** "BBB@ I*6B@!**** "DI:* $HI:2@04444 )12TE,
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M\>K?[Y_D*RCN=53X2]1116A@+124M !1110 M%)2T %%%%(!<T4E% Q:***
M"EI** %HHHH **** "DI:* $HHHH *2EHH 2BBB@04444 )12TE, HHHH 2B
MEI* "DI:*!"44M)0 E)3J2@!*2G4E,0E)2T4 )3<4ZB@0VDQ3B*2F E)3J2@
M!*2EHH$-(I*=1B@!E%+BBF(;12TE AI%)3Z0B@!E%.Q24Q#:2G4E AN*2GTE
M,!M(13L4E AM)3Z;BF(2DIU)0 VDQ3J2@0VBG4F*!#:*6BF VC%+10(9BBG4
MA%,0E)2T4 )7>5P>*[RL*W0[,)U.7\2?\A&/_KD/YFDTK_CU;_?/\A2^)/\
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ML+'IDKP0<8[>F.:=VMP48/1,^BL4E<E\-_%K^,/"D=Y< "]@<P7.T8#, "&
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M +1244 +1110 4444 )12T4 )1110 E%+10 E%%% @I*6BF E%+24 %)2T4
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MB@!**6DI@%%%% "44M% "4444 )12TE A**6B@!M)3J2F E)2T4"$I"*=24
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MK3S?WMXL\<BR/Y04&(X)V9S^[;L>HK8\2_#AO$/PWTK0GDMTU;3+:%(;@D[
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M)/2M#P'>Z_>_VTVM7L=Y#'?-'9S11A4,8'.TA5W $[<GN#R::%+74YKXP_\
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M4^U;FD>&-8M?BCXJUF:SVZ??6HCMIO-0[VPG& <CH>H%&H.W0K? C_DGC_\
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MU%)2T +1244 +1110,6BDI: "BBB@!:*2EH ****0!FEI**!BT444 %+244
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MM+P"W%X'*I"57A<;2"<*3C(X%)%2U.BU&WGO--N;:VNFM)I8V1+A5W&,D8W
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M+F@!U%)1FD,=1244 .HS24M QV:*;2YI .HI**!CLT4E% #J6FTM(8M%)2T
M+124M !2TE% Q:*2EH *7-)10 M%)2T %%%%(!:*2B@8M%%% "T4E% "T444
M %%%% !24M% "4444 %:]9%:]3(TI]3E_$G_ "$8_P#KD/YFL8UL^)/^0C'_
M -<A_,UC'K54?B(Q7\,****ZCS!:*2EH *6DHH&+124M !2TE% "T4E+2&+F
MEIM+F@!:6DHH 6ES244#'44VES2 =124M Q:*2EH&.S13:4&D,=2TVEH =13
M:6@8[-+3:7-(8N:=3:* '4M-!I:0QU+3:7- Q:<#3*6@!]%-!I<TACJ,TE%
MQU+FFTM #J6FYI:0Q:6DHH =129HH&.S2TVBD ZEIN:6@8M+3:6@!:6FTM(8
MZBDI: "EI** %HHHH&+1249H 6BBB@!:*2B@!:***0!2TE% "T49HH&%+244
M +129I: "BBB@ I*6B@!*UZR:UJF1I3ZG-^(()I;^-HXG<>4!E5)[FL22-XF
MVR(R'&<,,5W]<WX@M;B:_C:*"611$!E$)&<FG2^(C%)NGH8-%6/L%Y_SZ3_]
M^S_A1]@O/^?2?_OV?\*ZKH\[EEV(**G^P7G_ #Z3_P#?L_X4OV"\_P"?2?\
M[]G_  HN@Y9=BO2U/]@O/^?2?_OV:/L%Y_SZ3_\ ?LT70<LNQ!15C[!>?\^D
M_P#W[-'V"\_Y])_^_9HN@Y9=B"BI_L%Y_P ^D_\ W[-+]AO/^?2?_OV:+H.6
M78KT58^P7G_/I/\ ]^S1]@O/^?2?_OV:+H?++L045/\ 8+S_ )])_P#OV:/L
M-Y_SZ3_]^S1=!RR[$%+FI_L-Y_SZS_\ ?LT?8;S_ )]9_P#OV:5T'++L0T5/
M]AO/^?6?_OV:/L-W_P ^L_\ W[-%T/EEV(:*G^PW?_/K/_W[-'V&[_Y]9_\
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C HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
MQ5']L1_\^UQ_X[_\561J>IV.CVZ37LI0.XCC1(VDDD<]%1%!9CU. #P">@-+
MINH6>KVS3V<C,J.8Y%DC:-XW'561@&4X(."!P0>A%'+$.>?<UO[8C_Y]KC\E
M_P#BJ3^V8O\ GVN/R7_XJJOEBJ.HZE9:5]G%V\@:YE\F%(H7E=VP6P%0$\!2
M2<8 '-'+$.>?<V/[9B_Y][C\E_\ BJ/[9B_Y][C\E_\ BJJ>4*/*%'+$.>?<
MM_VU%_S[W'Y+_P#%4?VU%_S[W'Y+_P#%53\H4>51RQ%SS[EO^VH?^?>X_)?_
M (JC^VX?^?>X_)?_ (JJ?DBJNHWEGI5FUW>S"*%2!G!)8DX"J!RS$\  $D]*
M?+$.>IW-;^VX?^?>X_)?_BJ/[;A_Y][C\E_^*K$TW4K'5A+]D>3?"0)(IH'A
MD3(R,HX# 'L<8/:I+VZM=.6%KJ3RQ-,EO'\I.Z1SA1P.Y[]*.6(<]0U_[<@_
MY][C\E_QI/[<@_Y][C\E_P :R+"ZM=4LUN[*3S8&9E#[2N2K%6X.#U!%0MJF
MG+KRZ&;C&HM;_:1#L;F/<5SNQMZ@\9SQTHY8ASU#=_MR#_GA<?DO^-']NP?\
M\+C\E_QK!LM4T[4=1O\ 3[2X$MUI[*ER@4CRRPR!DC!X!Z$X[U?\CVHY8B]I
M4+_]NP?\\+C\E_QH_MVW_P">%Q^2_P"-9_D>U96F:[I.LW#0V-RTCA2ZEH71
M94!VEHV8 2*#@;E)'(YY%'+ /:5#I/[>M_\ GA<?DO\ C1_;UO\ \\+C\E_Q
MK(O);>PLY;JZD6*")=SN>P_J?8<FL^#7M)GL[VZ^T/%'8C=<K<020O$,9!*.
MH;!'0XYP0,XHY8![2J=/_;UO_P \+C\E_P :/[>M_P#GA<?DO^-<N-?TIM.:
M^$TOE+-Y!C-M()O,_N>5MW[L'.-N<<].:9_PD.D&Q2[6>5U>5H%B2VE:;S%S
MN7R@N\$ $D;>!STHY8![2K_2.K_M^V_YX7'Y+_C1_;]M_P \+C\E_P :PM/N
M;75+*.\LI1+ ^<-@@@@X((/(((((."",&K/D>U/D@+VM0T_[?MO^>%Q^2_XT
M?\)!;?\ /&X_)?\ &LOR*/(]J.2 O:U#4_X2"V_YXW'Y+_C1_P )!:_\\;C\
ME_QK*\CVI/(]J.2 >UJFM_PD-K_SQN/R7_&C_A(;7_GC<?\ ?*_XUD>1[4>1
M[4^2 O;536_X2&U_YXW'_?*_XT?\)#:_\\;C_OE?\:R/(]J3R/:CD@'MJIL?
M\)%:_P#/&X_[Y7_&C_A(K3_GC/\ ]\K_ (UC>1[4GD>U'LX![:J;7_"16G_/
M&?\ [Y7_ !H_X2*T_P">5Q_WRO\ C6+Y'M2>1[4>S@+VU4V_^$CM/^>5Q_WR
MO^-'_"1VG_/*X_[Y7_&L/R/:CR/:G[. >WJFW_PD=I_SRG_[Y7_&C_A([3_G
ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
MQ5']L1_\^UQ_X[_\561J>IV.CVZ37LI0.XCC1(VDDD<]%1%!9CU. #P">@-+
MINH6>KVS3V<C,J.8Y%DC:-XW'561@&4X(."!P0>A%'+$.>?<UO[8C_Y]KC\E
M_P#BJ3^V8O\ GVN/R7_XJJOEBJ.HZE9:5]G%V\@:YE\F%(H7E=VP6P%0$\!2
M2<8 '-'+$.>?<V/[9B_Y][C\E_\ BJ/[9B_Y][C\E_\ BJJ>4*/*%'+$.>?<
MM_VU%_S[W'Y+_P#%4?VU%_S[W'Y+_P#%53\H4>51RQ%SS[EO^VH?^?>X_)?_
M (JC^VX?^?>X_)?_ (JJ?DBJNHWEGI5FUW>S"*%2!G!)8DX"J!RS$\  $D]*
M?+$.>IW-;^VX?^?>X_)?_BJ/[;A_Y][C\E_^*K$TW4K'5A+]D>3?"0)(IH'A
MD3(R,HX# 'L<8/:I+VZM=.6%KJ3RQ-,EO'\I.Z1SA1P.Y[]*.6(<]0U_[<@_
MY][C\E_QI/[<@_Y][C\E_P :R+"ZM=4LUN[*3S8&9E#[2N2K%6X.#U!%0MJF
MG+KRZ&;C&HM;_:1#L;F/<5SNQMZ@\9SQTHY8ASU#=_MR#_GA<?DO^-']NP?\
M\+C\E_QK!LM4T[4=1O\ 3[2X$MUI[*ER@4CRRPR!DC!X!Z$X[U?\CVHY8B]I
M4+_]NP?\\+C\E_QH_MVW_P">%Q^2_P"-9_D>U96F:[I.LW#0V-RTCA2ZEH71
M94!VEHV8 2*#@;E)'(YY%'+ /:5#I/[>M_\ GA<?DO\ C1_;UO\ \\+C\E_Q
MK(O);>PLY;JZD6*")=SN>P_J?8<FL^#7M)GL[VZ^T/%'8C=<K<020O$,9!*.
MH;!'0XYP0,XHY8![2J=/_;UO_P \+C\E_P :/[>M_P#GA<?DO^-<N-?TIM.:
M^$TOE+-Y!C-M()O,_N>5MW[L'.-N<<].:9_PD.D&Q2[6>5U>5H%B2VE:;S%S
MN7R@N\$ $D;>!STHY8![2K_2.K_M^V_YX7'Y+_C1_;]M_P \+C\E_P :PM/N
M;75+*.\LI1+ ^<-@@@@X((/(((((."",&K/D>U/D@+VM0T_[?MO^>%Q^2_XT
M?\)!;?\ /&X_)?\ &LOR*/(]J.2 O:U#4_X2"V_YXW'Y+_C1_P )!:_\\;C\
ME_QK*\CVI/(]J.2 >UJFM_PD-K_SQN/R7_&C_A(;7_GC<?\ ?*_XUD>1[4>1
M[4^2 O;536_X2&U_YXW'_?*_XT?\)#:_\\;C_OE?\:R/(]J3R/:CD@'MJIL?
M\)%:_P#/&X_[Y7_&C_A(K3_GC/\ ]\K_ (UC>1[4GD>U'LX![:J;7_"16G_/
M&?\ [Y7_ !H_X2*T_P">5Q_WRO\ C6+Y'M2>1[4>S@+VU4V_^$CM/^>5Q_WR
MO^-'_"1VG_/*X_[Y7_&L/R/:CR/:G[. >WJFW_PD=I_SRG_[Y7_&C_A([3_G
ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WJXG6WA,K
M*S $#"]22<#^=5O[3'_/K/\ ^.?_ !5.U,XL6/\ MI_Z&*H>8*N,4T8SFU*R
M+O\ :8_Y]9__ !S_ .*H_M(?\^L__CG_ ,57+7?C#2+.]N[21KUY;3 N/(T^
MXF6/*AQED0K]T@]:V+>[AN[:*YMY4E@E021R(<AE(R"#Z$4^5$\\NYH_VD/^
M?6?_ ,<_^*H_M(?\^L__ (Y_\56=<WD-G:375P^R&%&DD;!.% R3@<]!5*R\
M0Z7J%^]C:W:O=)!'<F/:RGRW^ZW(Y_IQG&:.5!SR[F]_:0_Y]9__ !S_ .*H
M_M(?\^L__CG_ ,5678ZC;:E:BZM)?,A+.@;:1RK%6&#SP5(J3[7;BZ%J9X_M
M!0R"+>-Y4$ MCKC) S[T<J#GEW-#^TA_SZS_ /CG_P 51_:0_P"?6?\ \<_^
M*K+U#4;72]/N+^\E\JVMXS)*^TMM4#). "3^%6%D#*&4Y!&11RH.>7<N?VF/
M^?6?_P <_P#BJ/[3'_/K/_XY_P#%54W4NZCE0<\NY:_M,?\ /K/_ ..?_%4?
MVF/^?6?_ ,<_^*JKNK(OO%&F:?J3:?*;R2[6)9FCMK">XVHQ(!)C1@,E3U]*
M.5!SR[G0_P!IC_GUG_\ '/\ XJC^TQ_SZS_^.?\ Q58]IK-E>W;6D,D@N%@2
MX:*2%XV6-RP4D,!@Y5N#R,<BKVZCE0<\NY:_M,?\^L__ (Y_\51_:8_Y]9__
M !S_ .*JC!=6]R',$T<H1VC<QN&VN#@J<="#U%9-QXMT2UNY+>6Z<>3((IIA
M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
M%56R*3(HY4'/+N6O[3'_ #ZS_P#CG_Q5)_::_P#/K/\ ^.?_ !54KBYM[2!I
M[F:.&)<;I)'"J,G R3[D"I>*.5!SR[EC^U%_Y]9__'/_ (JC^U%_Y]9__'/_
M (JJ_%8X\3Z0=4&G?:9/.,Q@#FWD$+2@9,8EV["W!^4-G((ZC%%D'//N=!_:
MB_\ /K/_ ..?_%4?VHO_ #ZS_P#CG_Q58<'B'2KG5I=,BN6-U'N!!B=4)7&X
M*Y&UBNX9 )([]#45EXJT6_G,4%X0?*:9'FADB26->KQNZA749!W*2,$'H:+1
M'S3[G0_VHO\ SZS_ /CG_P 51_:B_P#/K/\ ^.?_ !586F>(M+U>Y>WM)I?.
M6,3!)[:2$O&3@.F]1O7/=<CD>HIE]XETS3]2;3YC>27:Q+,T=M83W&U&) ),
M:,!DJW7THM$7-/N=!_:J_P#/K<?^.?\ Q5']JK_SZW'_ (Y_\5619ZO8W]T]
MK!))]HCACG>*2%XV5'W!20P&"=K<=1CD"KV*+(.>?<L_VJO_ #ZW'_CO_P 5
M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
MQ59L5_:3ZC<Z?'+NNK9(Y)H]I&U7W;3G&#G8W3THO+^UL)+2.YE\MKN<6\ V
MD[Y"K-C@<<*QR>.*+1#GGW-+^UD_Y]KC_P =_P#BJ/[63_GVN/\ QW_XJL+5
M->T[2+JWM;IKEKBX1WBBM[26=F5<!CB-6P!N7KZU/IFJ66L6S7%E(SHDC1.K
MQ-&Z..JLC ,IZ<$#@@]Z5HAS3[FM_:R?\^UQ_P"._P#Q5']KQ_\ /M<?^.__
M !55=@HV4^6(N>?<L_VO'_S[7'_CO_Q5']KQ_P#/M<?^._\ Q58\FKZ;#>W%
MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
MQ59L5_:3ZC<Z?'+NNK9(Y)H]I&U7W;3G&#G8W3THO+^UL)+2.YE\MKN<6\ V
MD[Y"K-C@<<*QR>.*+1#GGW-+^UD_Y]KC_P =_P#BJ/[63_GVN/\ QW_XJL+5
M->T[2+JWM;IKEKBX1WBBM[26=F5<!CB-6P!N7KZU/IFJ66L6S7%E(SHDC1.K
MQ-&Z..JLC ,IZ<$#@@]Z5HAS3[FM_:R?\^UQ_P"._P#Q5']KQ_\ /M<?^.__
M !55=@HV4^6(N>?<L_VO'_S[7'_CO_Q5']KQ_P#/M<?^._\ Q58\FKZ;#>W%
MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
M?G_[*NDHHYY=Q^QAV.;_ .$8N_\ H,/_ -^?_LJ/^$8N_P#H,/\ ]^?_ +*N
MDHHYY=P]C#L<W_PC-W_T&'_[\_\ V5'_  C-Y_T&'_[\_P#V5=)11SR[A[&'
M8YO_ (1F\_Z##_\ ?G_[*C_A&;S_ *##_P#?G_[*NDHI<\@]C#L<W_PC-Y_T
M&7_[\_\ V5'_  C5Y_T&7_[\_P#V5=)11SR#V,.QSG_"-7G_ $&7_P"_/_V5
M'_"-7G_09?\ [\__ &5='11SR#V,.QSG_"-7O_09D_[\_P#V5'_"-7O_ $&9
M/^_/_P!E71T4<\@]E#L<Y_PC5[_T&9/^_/\ ]E1_PC5[_P!!F3_OS_\ 95T=
M%'/(/90['.?\(W>_]!J3_OU_]E1_PC=[_P!!J3_OU_\ 95T=%'/(/90['.?\
M(W>_]!J3_OU_]E1_PC=[_P!!J3_OU_\ 95T=%'/(/90['.?\(W>_]!J3_OU_
M]E1_PC=]_P!!J3_OU_\ 95T=%'/(/90['._\(W??]!J3_OU_]E1_PCE]_P!!
MJ3_OU_\ 95T5%'/(/90['._\(Y??]!J3_OU_]E1_PCE]_P!!J3_OU_\ 95T5
M%'/(/90['._\(Y??]!J3_OU_]E1_PCE]_P!!J3_OU_\ 95T5%'/(/90['._\
M(Y??]!J3_OU_]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\(Y??]!N7_OU_
M]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\(Y??]!N7_OU_]E1_PCE]_P!!
MN7_OU_\ 95T5%'/(/90['._\(Y??]!N7_OU_]E1_PCE]_P!!N7_OU_\ 95T5
M%'/(/90['._\(Y??]!N7_OU_]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\
M(Y??]!N7_OU_]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\([?_ /0;E_[]
M?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4.QSO_".W_P#T&Y?^_7_V5'_".W__
M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WJXG6WA,K
M*S $#"]22<#^=5O[3'_/K/\ ^.?_ !5.U,XL6/\ MI_Z&*H>8*N,4T8SFU*R
M+O\ :8_Y]9__ !S_ .*H_M(?\^L__CG_ ,57+7?C#2+.]N[21KUY;3 N/(T^
MXF6/*AQED0K]T@]:V+>[AN[:*YMY4E@E021R(<AE(R"#Z$4^5$\\NYH_VD/^
M?6?_ ,<_^*H_M(?\^L__ (Y_\56=<WD-G:375P^R&%&DD;!.% R3@<]!5*R\
M0Z7J%^]C:W:O=)!'<F/:RGRW^ZW(Y_IQG&:.5!SR[F]_:0_Y]9__ !S_ .*H
M_M(?\^L__CG_ ,5678ZC;:E:BZM)?,A+.@;:1RK%6&#SP5(J3[7;BZ%J9X_M
M!0R"+>-Y4$ MCKC) S[T<J#GEW-#^TA_SZS_ /CG_P 51_:0_P"?6?\ \<_^
M*K+U#4;72]/N+^\E\JVMXS)*^TMM4#). "3^%6%D#*&4Y!&11RH.>7<N?VF/
M^?6?_P <_P#BJ/[3'_/K/_XY_P#%54W4NZCE0<\NY:_M,?\ /K/_ ..?_%4?
MVF/^?6?_ ,<_^*JKNK(OO%&F:?J3:?*;R2[6)9FCMK">XVHQ(!)C1@,E3U]*
M.5!SR[G0_P!IC_GUG_\ '/\ XJC^TQ_SZS_^.?\ Q58]IK-E>W;6D,D@N%@2
MX:*2%XV6-RP4D,!@Y5N#R,<BKVZCE0<\NY:_M,?\^L__ (Y_\51_:8_Y]9__
M !S_ .*JC!=6]R',$T<H1VC<QN&VN#@J<="#U%9-QXMT2UNY+>6Z<>3((IIA
M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
M?G_[*NDHHYY=Q^QAV.;_ .$8N_\ H,/_ -^?_LJ/^$8N_P#H,/\ ]^?_ +*N
MDHHYY=P]C#L<W_PC-W_T&'_[\_\ V5'_  C-Y_T&'_[\_P#V5=)11SR[A[&'
M8YO_ (1F\_Z##_\ ?G_[*C_A&;S_ *##_P#?G_[*NDHI<\@]C#L<W_PC-Y_T
M&7_[\_\ V5'_  C5Y_T&7_[\_P#V5=)11SR#V,.QSG_"-7G_ $&7_P"_/_V5
M'_"-7G_09?\ [\__ &5='11SR#V,.QSG_"-7O_09D_[\_P#V5'_"-7O_ $&9
M/^_/_P!E71T4<\@]E#L<Y_PC5[_T&9/^_/\ ]E1_PC5[_P!!F3_OS_\ 95T=
M%'/(/90['.?\(W>_]!J3_OU_]E1_PC=[_P!!J3_OU_\ 95T=%'/(/90['.?\
M(W>_]!J3_OU_]E1_PC=[_P!!J3_OU_\ 95T=%'/(/90['.?\(W>_]!J3_OU_
M]E1_PC=]_P!!J3_OU_\ 95T=%'/(/90['._\(W??]!J3_OU_]E1_PCE]_P!!
MJ3_OU_\ 95T5%'/(/90['._\(Y??]!J3_OU_]E1_PCE]_P!!J3_OU_\ 95T5
M%'/(/90['._\(Y??]!J3_OU_]E1_PCE]_P!!J3_OU_\ 95T5%'/(/90['._\
M(Y??]!J3_OU_]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\(Y??]!N7_OU_
M]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\(Y??]!N7_OU_]E1_PCE]_P!!
MN7_OU_\ 95T5%'/(/90['._\(Y??]!N7_OU_]E1_PCE]_P!!N7_OU_\ 95T5
M%'/(/90['._\(Y??]!N7_OU_]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\
M(Y??]!N7_OU_]E1_PCE]_P!!N7_OU_\ 95T5%'/(/90['._\([?_ /0;E_[]
M?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4.QSO_".W_P#T&Y?^_7_V5'_".W__
M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
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ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J LT# 2(  A$! Q$!_\0
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M!(T,3G'RO*%V(>5X9AU'K19!SR[G2?VF/^?6?_QS_P"*H_M,?\^L_P#XY_\
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M2?VJG_/M<?\ CG_Q55]M&VGRH.>?<L?VJG_/M<?^._\ Q5']K)_S[3_^._\
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MI-=QQ36Z1/*)#M51(Q5/F/&68$ 9SG'J*O[!1RQ#GGW+/]L1_P#/M<?^._\
MQ5']L1_\^UQ_X[_\561J>IV.CVZ37LI0.XCC1(VDDD<]%1%!9CU. #P">@-+
MINH6>KVS3V<C,J.8Y%DC:-XW'561@&4X(."!P0>A%'+$.>?<UO[8C_Y]KC\E
M_P#BJ3^V8O\ GVN/R7_XJJOEBJ.HZE9:5]G%V\@:YE\F%(H7E=VP6P%0$\!2
M2<8 '-'+$.>?<V/[9B_Y][C\E_\ BJ/[9B_Y][C\E_\ BJJ>4*/*%'+$.>?<
MM_VU%_S[W'Y+_P#%4?VU%_S[W'Y+_P#%53\H4>51RQ%SS[EO^VH?^?>X_)?_
M (JC^VX?^?>X_)?_ (JJ?DBJNHWEGI5FUW>S"*%2!G!)8DX"J!RS$\  $D]*
M?+$.>IW-;^VX?^?>X_)?_BJ/[;A_Y][C\E_^*K$TW4K'5A+]D>3?"0)(IH'A
MD3(R,HX# 'L<8/:I+VZM=.6%KJ3RQ-,EO'\I.Z1SA1P.Y[]*.6(<]0U_[<@_
MY][C\E_QI/[<@_Y][C\E_P :R+"ZM=4LUN[*3S8&9E#[2N2K%6X.#U!%0MJF
MG+KRZ&;C&HM;_:1#L;F/<5SNQMZ@\9SQTHY8ASU#=_MR#_GA<?DO^-']NP?\
M\+C\E_QK!LM4T[4=1O\ 3[2X$MUI[*ER@4CRRPR!DC!X!Z$X[U?\CVHY8B]I
M4+_]NP?\\+C\E_QH_MVW_P">%Q^2_P"-9_D>U96F:[I.LW#0V-RTCA2ZEH71
M94!VEHV8 2*#@;E)'(YY%'+ /:5#I/[>M_\ GA<?DO\ C1_;UO\ \\+C\E_Q
MK(O);>PLY;JZD6*")=SN>P_J?8<FL^#7M)GL[VZ^T/%'8C=<K<020O$,9!*.
MH;!'0XYP0,XHY8![2J=/_;UO_P \+C\E_P :/[>M_P#GA<?DO^-<N-?TIM.:
M^$TOE+-Y!C-M()O,_N>5MW[L'.-N<<].:9_PD.D&Q2[6>5U>5H%B2VE:;S%S
MN7R@N\$ $D;>!STHY8![2K_2.K_M^V_YX7'Y+_C1_;]M_P \+C\E_P :PM/N
M;75+*.\LI1+ ^<-@@@@X((/(((((."",&K/D>U/D@+VM0T_[?MO^>%Q^2_XT
M?\)!;?\ /&X_)?\ &LOR*/(]J.2 O:U#4_X2"V_YXW'Y+_C1_P )!:_\\;C\
ME_QK*\CVI/(]J.2 >UJFM_PD-K_SQN/R7_&C_A(;7_GC<?\ ?*_XUD>1[4>1
M[4^2 O;536_X2&U_YXW'_?*_XT?\)#:_\\;C_OE?\:R/(]J3R/:CD@'MJIL?
M\)%:_P#/&X_[Y7_&C_A(K3_GC/\ ]\K_ (UC>1[4GD>U'LX![:J;7_"16G_/
M&?\ [Y7_ !H_X2*T_P">5Q_WRO\ C6+Y'M2>1[4>S@+VU4V_^$CM/^>5Q_WR
MO^-'_"1VG_/*X_[Y7_&L/R/:CR/:G[. >WJFW_PD=I_SRG_[Y7_&C_A([3_G
ME/\ ]\K_ (UA^1[4GD>U'LX![>J;O_"1VG_/*?\ [Y7_ !H_X2.T_P">4_\
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M5'_"+7/_ $%C_P!^/_LJZ:BCVDNX>QI]CF?^$6N?^@LW_?C_ .RI?^$6N?\
MH+-_WX_^RKI:*.>7</8T^QS7_"+7/_06;_OQ_P#94?\ "+7/_06;_OQ_]E72
MT4<\NX>QI]CFO^$6NO\ H+-_WX_^RH_X1>Z_Z"[?]^/_ +*NEHHYY=P]C#L<
MU_PB]U_T%V_[\?\ V5'_  B]U_T%V_[\_P#V5=+11SR[A[&'8YK_ (1>Z_Z"
M[?\ ?G_[*C_A%[K_ *"[?]^?_LJZ6BCGEW#V,.QS7_"+W7_07;_OS_\ 94?\
M(Q=_]!=O^_/_ -E72T4<\NX>QAV.;_X1B[_Z##?]^?\ [*C_ (1B[_Z##_\
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M $&Y?^_7_P!E7144<\@]E#L<[_PCM_\ ]!N7_OU_]E1_PCM__P!!N7_OU_\
M95T5%'/(/90['._\([?_ /0;E_[]?_94?\([?_\ 0;E_[]?_ &5=%11SR#V4
D.QD:9HTUC>FYFOVN28S& T>,9(/7)]*UZ**3;>Y<8J*LC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140156555710184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>radnet_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20220509.xsd" xlink:type="simple"/>
    <context id="From2022-05-09to2022-05-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-05-09</startDate>
            <endDate>2022-05-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-05-09to2022-05-09">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-05-09to2022-05-09">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-05-09to2022-05-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-05-09to2022-05-09">2022-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-05-09to2022-05-09">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-05-09to2022-05-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-05-09to2022-05-09">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-05-09to2022-05-09">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-05-09to2022-05-09">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-05-09to2022-05-09">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-05-09to2022-05-09">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-05-09to2022-05-09">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-05-09to2022-05-09">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-05-09to2022-05-09">478-7808</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-05-09to2022-05-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-05-09to2022-05-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-05-09to2022-05-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-05-09to2022-05-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-05-09to2022-05-09">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-09to2022-05-09">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-09to2022-05-09">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-05-09to2022-05-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>23
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MDI2I5+"(]%3O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ DI2I5)E<G",0!@  G"<  !,
M ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "2E*E4X,UJ
M+B@$   ?$   &               @($."   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ DI2I5)^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  P!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_8k.htm">radnet_8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20220509.xsd</File>
    <File>rdnt-20220509_lab.xml</File>
    <File>rdnt-20220509_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "radnet_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20220509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20220509_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20220509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20220509",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2022-05-09to2022-05-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2022-05-09to2022-05-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>29
<FILENAME>0001683168-22-003357-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-003357-xbrl.zip
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M4 6 !W"&A*_?+Q0[J85@+"%29#AZNSL]4Q_;?18T&JP"BBVDD"ZX6;Z#RRE
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MN/Z'SIE$&F;:NLLU#Q"F4:B\ALVP7\H5M=!@,) %2 $/,'_(V8 0\F^)D,Z
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M0=@6R'9\E B KF O8@D]'*HIT!=MPM"46PF( NN,,-Z%L3<$,9B8XLQTFD+
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M@*[?:6]MX3<6UQZ(1 =SU ]<3\Q(%D74XSZ4;[0AT30W3+"*\C*DDRAEX/&
MT=M722U'Y)N@P@+&!B;;)!(8+0TSV,GG(QQ#XHLH@=&<S4'RX(PPFN;%NMO+
M_,VYCA4A)H49$?^2K@S9YP)4+!/[+<O?/2 4;E">GHAG'UR.^44L8HNZD)OB
M8ELL()?@4F)RV+2],-6$="M=\S5LYC(&[BKK @[63R[!"T+!%4Y#DA2QCP/A
MLR#J]Z::5:Q.0":M8>G'V!1_RH@G<0PLD#5,CVI&1;;2 0-RA@&V8\<BS*"$
M!/+"8,SS'F-9$_JR4$V@RB8@;DO[3BP?'] G?2P3%#^A[!!M*")-(OH)DS1
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M9!NNFFG#I[7N?"NJ+2J':HL=5%M47GRUQ;8I+?ELZ&1:DY$_DKIXV[JX:O=
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M"]XN2$K[$*\(?L[(D!(;9F)_@8>GIF(K7[KFN%0I%%\SX!18NL8&'-@)YB?
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M#:G_*"]D>6D"R+7-299D,OJQ#7YV'7"S>?T^-)[FM.5K ;8@NTJZ@",""!@
M\91M+2:D^D=#>8FM97H%#+5JD@/S#40SYG>DR6A$Z.M8-J:=Y!6-F?'>N4!J
MU(;DB)_C8UEBAN7"'=&)0.)^S=%=H>3IFI.;I".G39BDE=BMC-J6X[PG:WW.
MQO@RY>R6IE]>TG](Y_\U"-"];&A]?R$1'PY.CNGD>A&SD5UQG=>HS7[N9?HV
MC"6HT[K! FMH.0@V"V8 *RJIM$YP2_5#-W:JB#VS_@2F;N9?<&?8K73ROL[]
MZA:,\,-Y!<%,"DO8JLHQR2)IS"LX,_ELVT:,@U0RB8SEDARP@#DNF5T*S,"?
MF_0(CL/-(,([K]":IA+2O^B^=^)PG/!)U"LQTRR"0/PXYQ]S4FC'CQL.!.>"
MH*@'L+7JYW"R@M1(I1X#+7=[S/IS<!3Z.B/16&WB+,H*7@X[$$C*3\?# 4XE
MJT_P <[*_UKEGI$T:7L\W)F<1"NZ/TX\//3.Y(']>QP]OV:O8-BXT<@R,NUF
MD1K#X>#.V:-'H^/C8_PT])EC'@\^O7,ZON\?#9^OFRP:>5=9<CL,)N0,?.Z"
M!+Z$:AEMTP_Q>W=-?O/0*N! 6Y=I%DU8 I'9F69IM7289YPT'"N/-%3.:=[2
MD5I <O89#/HM([2V&1]@/*GM#TPFL6+YXLAGC<*GD$.\@O(BGT5 ,%&UI35<
MR6E*FT#B_./H(F^O\[I,QS7JF#/IE-5O0:N\PBE]M"J2F N9-#- -FX5LQJE
MG48[H(9 :'W0<#"/9T N>+]H]WTZ#ZDWQ>Y#K-"HO<\X^AL".OO#[TRN?PG8
M6\L8B%C8@+^;E7'RB!$!L+G#(4Z.3W84;C6R8J'NC!K@9YFN^R+J>J##'/;@
M9+: DU&8PA'LK$R*A(O8BA51@"VKB+P.[BN>+?EB!M:>'7LX1COY-+]98G/=
M64MU)-O$*5OMX6H,![8<[(N&)JC+?RVV$K!QN9NG!FI4#R%81<M:&YR]3:!;
M*E?0',"1<SH-00'XT#5#AWPI'$-2U&C5"V.NC1NIQIV1RF4,@V3T\'!YP](M
MZ-\<EJH:<<-GC%*P&EA]:4 W^R)T?7K*AR3#[MTFPSY#,NS>;3+L(Z>I'O0P
M3?5,' -H<&_ANOF<:Z/4VC> !Y\'JW1&VO]&C]:.)HY@S<A3Y()I)&JP:NS8
MI+\U:6(&5NOA()M5TH\DVCKCC(U8?6S]) JMH^.;[:42NS8K8K;^9S&?G.RT
MD-4HA^IA?&W,1D"]72O^(RGDV++[SUF/\)6P0^%4SS@8;0@M44&(DTF <+:=
M919.1LU\!\"S#P("'4!MOIB=G_02B/W0G:LP>37IR1EXO@-O1 X+'D"3Q^:$
M&4!&O$>.VE[OT+(8J;A$'!O@Z.GI^)0QY149;)C3J;@T99PR5FIR<L2Q6'7X
M)*X:2&-6%8IP0CB&\3O?,/Q(RO@P.H^JPVZY\^!X_"#T*&<QH._,%B3N8Y,G
M9;S))4.+0=^9/#KS5Y";6F0LS&2'T1#,5NQ+8..U%(M4Y#YE M,UGVX4/7_W
M&N9B+=!?=NYIJK&&9S2GN&KD_?#6,.>RR:*-6DVEB$4"J7E"#S9H>XB03',?
M$9"]&G(L,->$[>5*/*D@?@JP6NC 25(^H+I0Q<8H/2UM<)[T0[)J'HO/#B4N
MN0P"MYV0L874).,Z'@Y^7J:9!_W!^_79 ?!J6)10S'5+_EL$K:T;8M$.G88Y
MO3+B]-'*U<L"Q3Z9+U%*UQGO /8GR:VAWP\'_)K[Z *OL_LAL1_"\81TWU1"
MFD;QA)JS@'@GC)H'I6;F$.X7F@6 4$W\+YE'B^:9#T"N,L(ZLN3P[>%B";<(
M0TIZ,O_*_S0<])< :J3L33U9,=22( *UD(P!*>@R=7/.<G&B=T_B.4ERLE<;
M&=<H-N'SVF\9P=9>[*A_%G\C#XC(8ENA[C'0<URMR;^:(U?#@'X$%#QP75D#
M4-=.%UNY1*O4PH)ZMA9QYZK-KN'66@2JF9A.GLS1:3&K)!R9X! ZL.W#'3\<
MA*.WI\2YU='3_7<XNW8 8*,P8BTX,*DB((W_:Y.+E>KM>R8@0!3KR'%Y@L2\
M,1U2A=,3N<RCU=8T,J/*+1%;R6%-J[#R*8#AP'( &B&#V9X7^=%?SL_?!!._
MHJG%N<PFAA7-)FZ><F7F3O$)Z)LL%2C^L2^\'45U_#O>*'%D*<Q2$4TNLHI7
M,';_'D#AI1R%'J")%3(1%LPA5LB)1"^Y+LC$@@"2WY^NU49FT4]SIJTL2KYZ
MI,F07(QCFC@:74-GC'*%Y F_->S8X0#WJK<<H'-YQ0,:'ZJPD<'IKS7S+V_-
M/ M(/B%ZPT0+.Y97U4R5Y8M.U6(6>SR>OP5L#QX2C# R6@1U[\N7N3J+S/<X
M "8%*P%SREX(<X"ZV+@H$^$ZX8*!W!WAM%<*"%H70?B ;2-,W2(75B1C,,?"
MH<5&)FNJ9H@/9Z%RF.Y>Q>Q.$^UAN"3=U8#28\.2/4KZ2<@J"EN/[A76U^+5
M=+X3[R#YF=*-WY/]ZTDLR'E($['%<,ZT)'[=XV4X.%2ZWY/)>*F^\34Y414;
M\9,A&N;M<!X "8&=%'NP"SDO>F\R[B9E]U*C;4F<*B&^]37..=V2[OB G ;+
MZ^Z7[-TY.1L_M&<R70N*^$;_R-.O*\[C>^R4V T'J+%CSS,8PZ1UWWD(J!%$
MZC"LA3_X!)M@O*KFG4?^0WBQ/*?^_3J1J%92_0+&>5N511\^'-_34L4[IY.S
M\6EXF^L+ _LAZGUZRH=D2\YNLR6?(5MR=ILM^<C9DH<]S);\K1NM/GSZ[;H4
MWFK? 2 =2D[8B2# J(>3"0.:;OCE1 [,._>#\YN^N>[PZY28WW#/ZTAJ#P]6
MSKN'XTEK0E22UB\E4GGGWMG81[T/TY[8LWMRBOW8VOH?,G?>4NK,G.08'K53
M=^.])N/H.;JW@*^E??H:93E+)0L^<"T__WA\?(9?@G)0P\S!"&)R,&^X+^3Z
M>#QY^ <B)124G ?9,,D) LR:P,D;@\[KDW0@G90!OCZ[/[[G)T-_PM4BNF7.
M3@*;J_-]7P3K/=.]<* G#N:MR9L*A)3('IA#R\$M8X^Y)E_;TC[=.3D.YHYN
MZ=UFQ!K4DS"_&YQ24;6) 2FZ<Q+H'DZ_5B)LF5L@EN9J(;6O@1NZ\^CT(>LT
M^R%#A$1+9 (CMPQ( LZ8JR+$3PD5.^()==E(5(L]1 9T;1T'#XTA+2T[;-RL
M)>^UIC2SR.@@JG 4:O(#=ET% 8^0:B&>(J;'TSMJ0PWLT'N_9,?AVO<@>.,]
M'(=;G],OLM.Z=VTW&Z[*W4*B#MAV9]?"RTW%]$3PSQ$;%7H]O&Z@B@[I'5Y>
M4;#8*AKP;67:K[S0R,KFT14->62=)LK8<;PSF01G7+A%/.5251=D@H<1L^&@
M(^J*7! A0=I/-9N-L%BWP3%LM3+EX@^^+_;:\<0PSLRVQ4'@=9Q:M#=W0; 7
M?4$8N$!W2F2_5(@->%EG?JV*X1156+%F1L6]A_8P_Z9A=)(5-I/V.P_C0"Z[
MT H5$MZ823X\>L(_V?]Z.)B#P2D6?CE/867UK=V\>-J;8KH; SI[1H!@4-=E
M"O[&@[Q%*'=4)JXVO#$Y&3_X<H2JS_VO2'5HL.7-B_=?'_K)?;IX'+V&D&5&
M\T4:7..CG/507,PN)IJ6+_8;J8*FHA?[_:@$,6*3U65<T56H7PHKEA&*U5R-
M7>S)G1Y^J72U-@N'V7)Z(ANO02-5D<-Z--."&-1A=R@:0<\G)-?R$_0,:3-
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MXJ5S:PM/D47LT!PF$+26VST$*&E++M]<.YR'#L*:@Z2_6MM'VY)6Y,MM- U
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M7B]H7S]]_?R7;_&7[]Z_^N';_P]02P,$%     @ DI2I5*BL[1\G P  I0L
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MYH=^:M@3NF [>%D+-)U,32]_ U!+ P04    " "2E*E4O^K2D/T*  " A@
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MIP@0_"GF2!%TBQ2!*R$RPA_H0JH:\/M*(._?,'E7>4/"_'=&E*&*KR&DC\1
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M971?.&LN:'1M4$L! A0#%     @ DI2I5/XBG>GU/@  DWL" !$
M     ( !6Q,  ')A9&YE=%]E>#DY,#$N:'1M4$L! A0#%     @ DI2I5%9_
M9$7O00  MV ! !$              ( !?U(  ')A9&YE=%]E>#DY,#(N:'1M
M4$L! A0#%     @ DI2I5*BL[1\G P  I0L  !$              ( !G90
M ')D;G0M,C R,C U,#DN>'-D4$L! A0#%     @ DI2I5+_JTI#]"@  @(8
M !4              ( !\Y<  ')D;G0M,C R,C U,#E?;&%B+GAM;%!+ 0(4
M Q0    ( )*4J50F;Y]35 <  -%7   5              "  2.C  !R9&YT
G+3(P,C(P-3 Y7W!R92YX;6Q02P4&      8 !@!^ 0  JJH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
